Ironwood Pharmaceuticals, Inc. ( IRWD) - Stock Earnings
IRWD Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 9, 2026, midnight | — / — | — | — / — | — |
IRWD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -2.3 million USD | 47.7 million USD |
| 2026Q1 | 40.8 million USD | 106.5 million USD |
| 2026Q2 | 51.3 million USD | 113.0 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
IRWD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -1.0 billion USD | 442.7 million USD |
| 2024 | 880000 USD | 351.4 million USD |
| 2025 | 24.0 million USD | 296.2 million USD |
| 2026 Est. | — | — |
IRWD
Price: $3.50
Earnings Per Share: 0.79 USD
P/E Ratio: 5.47
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 405820
Ebitda: 26.2 millionMarket Capitalization: 596.7 million